N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide

N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide Struktur
912908-32-8
CAS-Nr.
912908-32-8
Englisch Name:
N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide
Synonyma:
3-Isoxazolecarboxamide, N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydro-2-naphthalenyl)-;N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide
CBNumber:
CB74027428
Summenformel:
C24H22N4O5
Molgewicht:
446.46
MOL-Datei:
912908-32-8.mol

N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide Eigenschaften

Dichte
1.317±0.06 g/cm3(Predicted)
pka
9.65±0.70(Predicted)

Sicherheit

N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide Chemische Eigenschaften,Einsatz,Produktion Methoden

N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
sales@pharmeks.com Finland 6349 50
VITAS-M LABORATORY, LTD. --
Russia 6753 64
Interbioscreen Ltd. --
screen@ibscreen.chg.ru Finland 6176 60
OTAVA chemicals --
north.america@otavachemicals.com Ukraine 6495 72

  • N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2-oxazole-3-carboxamide
  • 3-Isoxazolecarboxamide, N-[4-(3,4-dimethoxyphenyl)-1,2,5-oxadiazol-3-yl]-5-(5,6,7,8-tetrahydro-2-naphthalenyl)-
  • 912908-32-8
Copyright 2019 © ChemicalBook. All rights reserved